Dr. Bonda Ann Abide, M.D., MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1120 Avon Pl, Greenville, MS 38701 Phone: 662-931-0490 |
News Archive
Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet.
The metropolitan Washington, D.C. region currently experiences health inequities related to access to care in underserved areas, disparities in chronic disease outcomes, provider shortages, and inadequate diversity of the health professions. Research has shown that a more diverse health care workforce can help address these problems.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that it has received CE Mark for expanded MR-conditional labeling.
A letter in this weeks BMJ reports on how researchers are urging rural clinics in India to stop the superstitious practice known as 'branding treatment'.
› Verified 8 days ago